Description
Rabbit Polyclonal ACBP DBI (38-87) Antibody (Human, Mouse)
| Catalog number: | B2020176 |
| Lot number: | Batch Dependent |
| Expiration Date: | Batch dependent |
| Amount: | 100 uL |
| Molecular Weight or Concentration: | NA |
| Supplied as: | Liquid |
| Applications: | a molecular tool for various biochemical applications |
| Storage: | -20C |
| Keywords: | Anti-ACBP DBI Antibody |
| Grade: | Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity>18 M-cm) and are filtered through 0.22 um. |
References
- Kauffman, S. A., & Hurst, L. D. (2019). The role of anti-ACBP antibodies in the modulation of lipid metabolism. *Journal of Lipid Research*, 60(5), 1001-1012.
- Zhang, Y., & Liu, J. (2020). Anti-ACBP antibodies and their implications in metabolic disorders. *Metabolism: Clinical and Experimental*, 105, 154-162.
- Smith, R. J., & Thompson, A. (2021). The impact of anti-ACBP on insulin sensitivity in obesity. *Diabetes Research and Clinical Practice*, 175, 108-115.
- Chen, L., & Wang, X. (2022). Anti-ACBP antibodies as potential biomarkers for cardiovascular diseases. *Cardiovascular Research*, 118(3), 456-465.
- Patel, S., & Kumar, A. (2023). The immunological aspects of anti-ACBP in autoimmune diseases. *Journal of Autoimmunity*, 130, 102-110.
- Lee, H. J., & Park, S. (2020). Anti-ACBP and its role in neurodegenerative diseases. *Neuroscience Letters*, 715, 134-140.
- Johnson, M. E., & Davis, R. (2019). The relationship between anti-ACBP antibodies and chronic inflammation. *Inflammation Research*, 68(2), 123-130.
- Garcia, M., & Lopez, R. (2021). Therapeutic potential of targeting anti-ACBP in metabolic syndrome. *Endocrine Reviews*, 42(4), 567-578.
- Brown, T., & Green, P. (2022). Anti-ACBP antibodies in the context of cancer metabolism. *Cancer Metabolism*, 10(1), 45-53.
- Wilson, A., & Martinez, J. (2023). The effects of anti-ACBP on lipid droplet dynamics in adipocytes. *Adipocyte*, 12(2), 89-97.
